4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-22-013475
Chairman and CEO bought 16,500 shares at an average $1.42 ($23,485)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2022-02-24 | Purchase | +11,000 | $1.43 | $15,730 | 11,244,206 | D |
| Niihara Yutaka Chairman and CEO | 2022-02-25 | Purchase | +5,500 | $1.41 | $7,755 | 11,249,706 | D |
| Open-market purchases · 16,500 sh · avg $1.42 · $23,485 | |||||||
Loading xslF345X03/doc4.xml…